Better Therapeutics, Inc.

Better Therapeutics, Inc.verified

BTTX

Price:

$0.0078

Market Cap:

$425.22K

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Fran...[Read more]

Industry

Biotechnology

IPO Date

2021-03-17

Stock Exchange

NASDAQ

Ticker

BTTX

The PE Ratio as of June 2024 (TTM) for Better Therapeutics, Inc. (BTTX) is -0.01

According to Better Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -98.62% compared to the average of -0.73 of the last 4 quarters.

Better Therapeutics, Inc. (BTTX) Historical PE Ratio (quarterly & annually)

How has BTTX PE Ratio performed in the past?

The mean historical PE Ratio of Better Therapeutics, Inc. over the last ten years is -13.98. The current -0.01 PE Ratio has changed -92.85% with respect to the historical average. Over the past ten years (40 quarters), BTTX's PE Ratio was at its highest in in the March 2023 quarter at -0.45. The PE Ratio was at its lowest in in the September 2021 quarter at -246.18.

Quarterly (TTM)
Annual

Average

-13.98

Median

-7.28

Minimum

-40.72

Maximum

-0.66

Better Therapeutics, Inc. (BTTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Better Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = -0.66

Minimum Annual Increase = -77.00%

Minimum Annual PE Ratio = -40.72

Quarterly (TTM)
Annual
YearPE RatioChange
2022-0.66-75.83%
2021-2.72-77.00%
2020-11.83-70.94%

Better Therapeutics, Inc. (BTTX) Average PE Ratio

How has BTTX PE Ratio performed in the past?

The current PE Ratio of Better Therapeutics, Inc. (BTTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-5.07

5-year avg

-13.98

10-year avg

-13.98

Better Therapeutics, Inc. (BTTX) PE Ratio vs. Peers

How is BTTX’s PE Ratio compared to its peers?

Better Therapeutics, Inc.’s PE Ratio is greater than ABVC BioPharma, Inc. (-0.56), greater than Indaptus Therapeutics, Inc. (-1.40), greater than Pasithea Therapeutics Corp. (-0.33), greater than Forte Biosciences, Inc. (-0.77), greater than Aerovate Therapeutics, Inc. (-0.48), greater than Adagene Inc. (-4.08), greater than Acrivon Therapeutics, Inc. Common Stock (-2.34), greater than Rezolute, Inc. (-3.39), greater than AN2 Therapeutics, Inc. (-0.90), greater than SAB Biotherapeutics, Inc. (-0.60), greater than Senti Biosciences, Inc. (-0.17), greater than Cingulate Inc. (-0.13), greater than Bellicum Pharmaceuticals, Inc. (-0.11), less than Hillstream BioPharma, Inc. (-0.00), greater than Miromatrix Medical Inc. (-3.41), greater than Inhibikase Therapeutics, Inc. (-0.49), greater than PMV Pharmaceuticals, Inc. (-1.27), greater than Anebulo Pharmaceuticals, Inc. (-5.68), greater than Acumen Pharmaceuticals, Inc. (-2.49), greater than HOOKIPA Pharma Inc. (-1.86), greater than Day One Biopharmaceuticals, Inc. (-5.55), greater than Inozyme Pharma, Inc. (-3.52), greater than Terns Pharmaceuticals, Inc. (-6.02),

Build a custom stock screener for Better Therapeutics, Inc. (BTTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Better Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Better Therapeutics, Inc. (BTTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Better Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Better Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Better Therapeutics, Inc. (BTTX)?

What is the highest PE Ratio for Better Therapeutics, Inc. (BTTX)?

What is the 3-year average PE Ratio for Better Therapeutics, Inc. (BTTX)?

What is the 5-year average PE Ratio for Better Therapeutics, Inc. (BTTX)?

How does the current PE Ratio for Better Therapeutics, Inc. (BTTX) compare to its historical average?